Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation.

MLA

Wensaas, Andreas J., et al. “Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation.” Diabetes, vol. 58, no. 3, Mar. 2009, pp. 527–35. EBSCOhost, https://doi.org/10.2337/db08-1043.

APA

Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M. (2009). Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation. Diabetes, 58(3), 527–535. https://doi.org/10.2337/db08-1043

Chicago

Wensaas, Andreas J., Arild C. Rustan, Marlene Just, Rolf K. Berge, Christian A. Drevon, and Michael Gaster. 2009. “Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation.” Diabetes 58 (3): 527–35. doi:10.2337/db08-1043.